Marker: D4Rat209 |
| Symbol: |
D4Rat209 |
| Previously known as: |
oxsts10930; R0105-B12;
|
| RGD ID: |
39732 |
| Expected Size: |
170 (bp) |
| Position |
| Rat Assembly | Chr | Position (strand) | Source | JBrowse |
|---|
GRCr8 | 4 | 9,577,533 - 9,577,703 (+) | Marker Load Pipeline | | mRatBN7.2 | 4 | 8,843,751 - 8,843,921 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 4 | 5,274,038 - 5,274,207 | NCBI | Rnor6.0 | Rnor_5.0 | 4 | 5,301,534 - 5,301,703 | UniSTS | Rnor5.0 | RGSC_v3.4 | 4 | 4,211,397 - 4,211,566 | UniSTS | RGSC3.4 | RGSC_v3.4 | 4 | 4,211,396 - 4,211,566 | RGD | RGSC3.4 | Celera | 4 | 1,461,634 - 1,461,803 | UniSTS | | RGSC_v3.1 | 4 | 4,211,396 - 4,211,566 | RGD | | FHH x ACI Map | 4 | 2.11 | RGD | | FHH x ACI Map | 4 | 2.11 | UniSTS | |
|
| Is Marker For: |
Strains:
ACI/N ;
AVN/Orl ;
BBDR/Rhw ;
BBDP/Rhw ;
BC/CpbU ;
BDIX/Han ;
BN-Lx/Cub ;
BN/SsNHsd ;
BP/Cub ;
BUF/Pit ;
COP/OlaHsd ;
DA/PitN ;
FHH/Eur ;
F344/Pit ;
GH/Omr ;
GK/KyoSwe ;
DON/Melb ;
M520/N ;
IS/Kyo ;
WN/N ;
LH/Mav ;
LE/Mol ;
LEW/Pit ;
LOU/CHan ;
LN/Mav ;
MHS/Gib ;
MNR/N ;
MNRA/N ;
MR/Pit ;
ODU/N ;
OKA/Wsl ;
SD/Rij ;
SR/Jr ;
SHRSP/Riv ;
SS/Jr ;
WAG/RijKyo ;
WF/Pit ;
WIST/Nhg ;
WKY/OlaHsd
|
QTLs in Region (GRCr8)
| 61408 | Scl23 | Serum cholesterol level QTL 23 | | 0.0005 | blood HDL phospholipid amount (VT:0010504) | serum high density lipoprotein phospholipid level (CMO:0001567) | 4 | 1 | 28392287 | Rat |
| 631209 | Bw2 | Body weight QTL2 | 4.2 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 4 | 1 | 45429897 | Rat |
| 8552803 | Bw144 | Body weight QTL 144 | 16 | | body mass (VT:0001259) | change in body weight to body weight ratio (CMO:0002216) | 4 | 1 | 35396961 | Rat |
| 8552801 | Bw143 | Body weight QTL 143 | 7.3 | | body mass (VT:0001259) | change in body weight to body weight ratio (CMO:0002216) | 4 | 1 | 35396961 | Rat |
| 2303168 | Bp330 | Blood pressure QTL 330 | 4.25 | 0.017 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 5889999 | 148002343 | Rat |
| 9589046 | Scfw2 | Subcutaneous fat weight QTL 2 | 5.54 | 0.001 | subcutaneous adipose mass (VT:1000472) | abdominal subcutaneous fat pad weight (CMO:0002069) | 4 | 1 | 32668025 | Rat |
| 8552903 | Pigfal2 | Plasma insulin-like growth factor 1 level QTL 2 | 7.3 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 4 | 1 | 32668025 | Rat |
| 724557 | Plsm1 | Polydactyly-luxate syndrome (PLS) morphotypes QTL 1 | | 0.0003 | forelimb integrity trait (VT:0010562) | front foot phalanges count (CMO:0001947) | 4 | 1 | 28392287 | Rat |
| 9590100 | Sffal4 | Serum free fatty acids level QTL 4 | 7.36 | 0.05 | blood free fatty acid amount (VT:0001553) | plasma free fatty acids level (CMO:0000546) | 4 | 1 | 32668025 | Rat |
| 61351 | Bp33 | Blood pressure QTL 33 | | 0.0018 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 1 | 28392287 | Rat |
| 61415 | Eae11 | Experimental allergic encephalomyelitis QTL 11 | 2.9 | | nervous system integrity trait (VT:0010566) | post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422) | 4 | 1 | 40471598 | Rat |
| 1641905 | Colcr1 | Colorectal carcinoma resistance QTL 1 | 4.3 | 0.0003 | intestine integrity trait (VT:0010554) | benign colorectal tumor surface area measurement (CMO:0001799) | 4 | 8428551 | 30449094 | Rat |
| 1357341 | Gluco5 | Glucose level QTL 5 | 6.4 | | adipocyte free fatty acid secretion trait (VT:0010465) | absolute change in adipocyte free fatty acid secretion per unit volume (CMO:0001446) | 4 | 1 | 34142783 | Rat |
| 619616 | Bp79 | Blood pressure QTL 79 | | 0.0292 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 5889999 | 50889999 | Rat |
| 1357343 | Gluco4 | Glucose level QTL 4 | | 0.00002 | adipocyte glucose uptake trait (VT:0004185) | adipocyte maximal glucose uptake to basal glucose uptake ratio (CMO:0000874) | 4 | 1 | 34142783 | Rat |
| 8552809 | Vie5 | Viral induced encephalitis QTL 5 | 25.3 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 4 | 1 | 35396961 | Rat |
| 8552782 | Vie1 | Viral induced encephalitis QTL 1 | 26.4 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 4 | 1 | 35396961 | Rat |
| 738021 | Hcar13 | Hepatocarcinoma resistance QTL 13 | 4.3 | | liver integrity trait (VT:0010547) | liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) | 4 | 1 | 33538816 | Rat |
| 70192 | BpQTLcluster5 | Blood pressure QTL cluster 5 | 4.183 | | arterial blood pressure trait (VT:2000000) | absolute change in mean arterial blood pressure (CMO:0000533) | 4 | 1 | 63900697 | Rat |
| 631642 | Stl2 | Serum triglyceride level QTL 2 | 3.3 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5894575 | 57613242 | Rat |
| 61333 | Gluco16 | Glucose level QTL 16 | 4.3 | 0.00001 | adipocyte glucose uptake trait (VT:0004185) | absolute change in adipocyte glucose uptake (CMO:0000873) | 4 | 1 | 31106810 | Rat |
| 9589097 | Slep11 | Serum leptin concentration QTL 11 | 5.09 | 0.001 | blood leptin amount (VT:0005667) | plasma leptin level (CMO:0000781) | 4 | 1 | 32668025 | Rat |